NYXOAH SA - ORDINARY SHARES
9.1200
12-3月-25 12:08:29
15 分の遅延
株式
+0.1400
+1.56%
本日の幅
8.9600 - 9.1800
ISIN
BE0974358906
ソース
Cboe
-
Nyxoah Announces Inaugural Investor & Analyst Meeting
21 2 2023 16:30:00 提供 Nasdaq GlobeNewswire
-
Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors
09 1 2023 16:30:00 提供 Nasdaq GlobeNewswire
-
Information on the total number of voting rights and shares
29 12 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program
22 12 2022 16:12:14 提供 Nasdaq GlobeNewswire
-
Nyxoah to Participate in the Piper Sandler 34th Annual Healthcare Conference
17 11 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
Nyxoah Reports Third Quarter 2022 Financial and Operating Results
08 11 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
Nyxoah Announces Change to Board of Directors
24 10 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
Nyxoah to Participate in the Jefferies London Healthcare Conference
20 10 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
Nyxoah to Release Third Quarter Financial Results on November 8, 2022
18 10 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
Information on the total number of voting rights and shares
30 9 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
Nyxoah to Participate in the 17th Annual Wells Fargo Securities Healthcare Conference
18 8 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results
08 8 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
02 8 2022 02:00:00 提供 Nasdaq GlobeNewswire
-
Nyxoah to Present at the Canaccord Genuity 42nd Annual Growth Conference
27 7 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
Nyxoah to Release Second Quarter and First Half 2022 Financial Results on August 8, 2022
19 7 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
Nyxoah Announces CE Mark Approval for Genio® 2.1
18 7 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
11 7 2022 02:00:00 提供 Nasdaq GlobeNewswire
-
Information on the total number of voting rights and shares
30 6 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
Nyxoah Joins the Euronext Tech Leaders Initiative, Included in the Euronext Tech Leaders Index
07 6 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
FDA Approves Genio® 2.1 For Use in DREAM U.S. IDE Pivotal Study
01 6 2022 16:30:00 提供 Nasdaq GlobeNewswire